rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Chia-Lin Simmons

President and CEO

Company insider

Files Form 4 as: President and CEO, LogicMark; Director, Pelthos Therapeutics.

In numbers

Trades disclosed
20
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
1
First trade
14 Jun 2021
Last trade
13 Oct 2026
Last filed
15 Oct 2026

Companies traded

Where they are an officer
LogicMarkDirector, Officer · Medical Devices · last 13 Oct 20260 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
PTHS Pelthos TherapeuticsDirector · Pharmaceuticals · last 11 Apr 20250 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
13 Oct 2026filed 15 Oct 2026LogicMarkMedical DevicesSEC FORM 4 Code D$98K74,965 at $1.31filing
3 Nov 2025filed 5 Nov 2025LogicMarkMedical DevicesSEC FORM 4 Code A—74,800 at $0.00filing
11 Apr 2025filed 15 Apr 2025PTHS Pelthos Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—25,000filing
27 Mar 2025filed 31 Mar 2025LogicMarkoption or derivative · Medical DevicesSEC FORM 4 Code A$8,81367,794 at $0.13filing
18 Feb 2025filed 20 Feb 2025LogicMarkoption or derivative · Medical DevicesSEC FORM 4 Code A$1,46111,238 at $0.13filing
2 Jan 2025filed 6 Jan 2025LogicMarkMedical DevicesSEC FORM 4 Code A—116,900 at $0.00filing
26 Nov 2024filed 29 Nov 2024LogicMarkoption or derivative · Medical DevicesSEC FORM 4 Code A$6314,851 at $0.13filing
26 Nov 2024filed 29 Nov 2024LogicMarkoption or derivative · Medical DevicesSEC FORM 4 Code A$6314,851 at $0.13filing
1 Oct 2024filed 3 Oct 2024LogicMarkoption or derivative · Medical DevicesSEC FORM 4 Code A$62862,772 at $0.01filing
1 Oct 2024filed 3 Oct 2024LogicMarkoption or derivative · Medical DevicesSEC FORM 4 Code A$21521,486 at $0.01filing
5 Aug 2024filed 3 Oct 2024LogicMarkMedical DevicesSEC FORM 4 Code A$9,88421,486 at $0.46filing
5 Aug 2024filed 6 Aug 2024LogicMarkoption or derivative · Medical DevicesSEC FORM 4 Code A$21521,486 at $0.01filing
5 Aug 2024filed 6 Aug 2024LogicMarkoption or derivative · Medical DevicesSEC FORM 4 Code A$21521,486 at $0.01filing
5 Aug 2024filed 6 Aug 2024LogicMarkMedical DevicesSEC FORM 4 Code A$9,88421,486 at $0.46filing
14 Jun 2024filed 18 Jun 2024PTHS Pelthos Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—90,000filing
3 Apr 2024filed 5 Apr 2024LogicMarkMedical DevicesSEC FORM 4 Code A—46,200 at $0.00filing
7 Aug 2023filed 9 Aug 2023LogicMarkMedical DevicesSEC FORM 4 Code A—62,000 at $0.00filing
3 Jan 2022filed 18 Feb 2022LogicMarkMedical DevicesSEC FORM 4 Code A—204,145 at $0.00filing
3 Jan 2022filed 4 Jan 2022LogicMarkMedical DevicesSEC FORM 4 Code A—204,145 at $0.00filing
14 Jun 2021filed 23 Jun 2021LogicMarkMedical DevicesSEC FORM 4 Code A—2,665,595 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

John P. PettittOther role · Other at LogicMark, filing Form 4 there in the last year
Robert Arthur CurtisOther role · Other at LogicMark, filing Form 4 there in the last year
Barbara GutierrezOther role · Other at LogicMark, filing Form 4 there in the last year
Mark ArcherChief Financial Officer · Chief Financial Officer at LogicMark, filing Form 4 there in the last year
Carine SchneiderOther role · Other at LogicMark, filing Form 4 there in the last year